{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T07:05:09Z","timestamp":1789110309622,"version":"build-2803163510"},"reference-count":7,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016545","name":"Roche Diagnostics Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["structuralheartjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Structural Heart"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.shj.2024.100357","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T17:36:21Z","timestamp":1725298581000},"page":"100357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Risk for Excessive Anticoagulation With Activated Clotting Time-Guided Monitoring in Patients Undergoing Transcatheter Aortic Valve Replacement"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9309-0011","authenticated-orcid":false,"given":"Thijmen W.","family":"Hokken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7749-334X","authenticated-orcid":false,"given":"Moniek P.M.","family":"de Maat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas M.","family":"Van Mieghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.shj.2024.100357_bib1","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.amjcard.2018.01.050","article-title":"Incidence, Predictors, and Impact of vascular complications after Transfemoral transcatheter aortic valve implantation with the SAPIEN 3 prosthesis","volume":"121","author":"van Kesteren","year":"2018","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.shj.2024.100357_bib2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11239-014-1118-x","article-title":"Antithrombotic therapy before, during and after transcatheter aortic valve replacement (TAVR)","volume":"39","author":"Sharma","year":"2015","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"4","key":"10.1016\/j.shj.2024.100357_bib3","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/eurheartj\/ehn008","article-title":"Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: insights from the STEEPLE trial","volume":"29","author":"Montalescot","year":"2008","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.shj.2024.100357_bib4","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jvs.2017.11.079","article-title":"Comparison between activated clotting time and anti-activated factor X activity for the monitoring of unfractionated heparin therapy in patients with aortic aneurysm undergoing an endovascular procedure","volume":"68","author":"Dieplinger","year":"2018","journal-title":"J\u00a0Vasc Surg"},{"issue":"11","key":"10.1016\/j.shj.2024.100357_bib5","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0735-1097(02)02531-7","article-title":"A\u00a0unique, low dose of intravenous enoxaparin in elective percutaneous coronary intervention","volume":"40","author":"Choussat","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.shj.2024.100357_bib6","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1592\/phco.19.11.922.31573","article-title":"Correlation of activated clotting time and activated partial thromboplastin time to plasma heparin concentration","volume":"19","author":"Koerber","year":"1999","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.shj.2024.100357_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1345\/aph.1A141","article-title":"Correlation between activated clotting time and activated partial thromboplastin times","volume":"36","author":"Smythe","year":"2002","journal-title":"Ann Pharmacother"}],"container-title":["Structural Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S247487062400112X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S247487062400112X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T21:48:17Z","timestamp":1763243297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S247487062400112X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S247487062400112X"],"URL":"https:\/\/doi.org\/10.1016\/j.shj.2024.100357","relation":{},"ISSN":["2474-8706"],"issn-type":[{"value":"2474-8706","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Risk for Excessive Anticoagulation With Activated Clotting Time-Guided Monitoring in Patients Undergoing Transcatheter Aortic Valve Replacement","name":"articletitle","label":"Article Title"},{"value":"Structural Heart","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.shj.2024.100357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of Cardiovascular Research Foundation.","name":"copyright","label":"Copyright"}],"article-number":"100357"}}